Not available outside of the UK & Ireland.
Biochem/physiol Actions
L-368,899 is a non-peptide oxytocin receptor (OTR) antagonist.
Features and Benefits
This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
5 mg in glass bottle
This product has met the following criteria to qualify for the following awards: